Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

RecruitingOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2025

Conditions
Prostate Cancer
Interventions
DEVICE

Siemens Magnetom Free.Max 0.55T (Siemens Healthineers, Erlangen, Germany).

Performing low-field MRI to evaluate image quality with patients carrying metallic implants and assess the detection of suspicious prostate lesions.

Trial Locations (1)

1011

RECRUITING

Lausanne University Hospital, Lausanne

All Listed Sponsors
lead

University of Lausanne Hospitals

OTHER